Get the Stockscreener App
1.61
0.62%
-0.01
Lava Therapeutics Nv stock is traded at $1.61, with a volume of 54,578.
It is down -0.62% in the last 24 hours and down -0.62% over the past month.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
See More
Previous Close:
$1.62
Open:
$1.6
24h Volume:
54,578
Relative Volume:
0.17
Market Cap:
$42.35M
Revenue:
$4.99M
Net Income/Loss:
$-28.29M
P/E Ratio:
-1.5293
EPS:
-1.0528
Net Cash Flow:
$-36.20M
1W Performance:
-0.92%
1M Performance:
-0.62%
6M Performance:
+28.49%
1Y Performance:
-12.50%
1-Day Range:
$1.59
$1.62
1-Week Range:
$1.59
$1.63
52-Week Range:
$0.8502
$2.00
Lava Therapeutics Nv Stock (LVTX) Company Profile
Name
Lava Therapeutics Nv
Sector
Industry
Phone
31 6 3000 3035
Address
YALELAAN 62, UTRECHT
Compare LVTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LVTX
Lava Therapeutics Nv
|
1.61 | 42.61M | 4.99M | -28.29M | -36.20M | -1.0528 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-11-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Oct-25-22 | Initiated | H.C. Wainwright | Buy |
| Apr-19-21 | Initiated | JP Morgan | Overweight |
| Apr-19-21 | Initiated | Jefferies | Buy |
| Apr-19-21 | Initiated | SVB Leerink | Outperform |
View All
Lava Therapeutics Nv Stock (LVTX) Latest News
LAVA Therapeutics Approves Merger with New Topco B.V. - TipRanks
Lava Therapeutics shareholders approve director appointments and merger resolutions - Investing.com
Will LAVA Therapeutics N.V. stock benefit from green energy trendsIndex Update & Advanced Swing Trade Entry Plans - newser.com
How to track smart money flows in LAVA Therapeutics N.V.Weekly Stock Recap & AI Driven Price Predictions - newser.com
Can LAVA Therapeutics N.V. (4PKB) stock expand revenue streamsRecession Risk & Daily Profit Maximizing Tips - newser.com
Why hedge funds are buying LAVA Therapeutics N.V. stockMarket Activity Report & Free Fast Gain Swing Trade Alerts - newser.com
Ranking LAVA Therapeutics N.V. among high performing stocks via toolsMarket Performance Report & Growth Focused Investment Plans - newser.com
Is LAVA Therapeutics N.V. showing signs of accumulationQuarterly Risk Review & Real-Time Buy Zone Alerts - newser.com
Historical volatility pattern of LAVA Therapeutics N.V. visualizedPortfolio Value Report & Long Hold Capital Preservation Tips - newser.com
Advanced analytics toolkit walkthrough for LAVA Therapeutics N.V.Market Growth Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
How analysts revise price targets for LAVA Therapeutics N.V. (4PKB) stockEarnings Recap Summary & Consistent Income Trade Recommendations - newser.com
Analyzing LAVA Therapeutics N.V. with risk reward ratio chartsInsider Selling & Verified Swing Trading Watchlist - newser.com
What analysts say about LAVA Therapeutics NV 4PKB stockDay Trading Setups & Free Expert Guidance For Growth - earlytimes.in
Price momentum metrics for LAVA Therapeutics N.V. explained2025 Investor Takeaways & Technical Buy Zone Confirmation - newser.com
How LAVA Therapeutics N.V. stock valuations compare to rivalsPrice Action & Real-Time Volume Trigger Notifications - newser.com
Heatmap analysis for LAVA Therapeutics N.V. and competitorsJuly 2025 Reactions & Real-Time Stock Movement Alerts - newser.com
Can LAVA Therapeutics N.V. hit a new high this monthMarket Growth Report & Fast Momentum Entry Tips - newser.com
CapEx per share of LAVA Therapeutics NV – FWB:4PKB - TradingView
What indicators show strength in LAVA Therapeutics N.V.Treasury Yields & High Accuracy Trade Signal Alerts - newser.com
Reversal indicators forming on LAVA Therapeutics N.V. stock2025 Volatility Report & Weekly High Return Opportunities - newser.com
Custom strategy builders for tracking LAVA Therapeutics N.V.Swing Trade & Daily Price Action Insights - newser.com
Lava Therapeutics Nv Stock (LVTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):